Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 3
1961 1
1963 1
1964 5
1965 2
1966 2
1967 1
2003 1
2004 2
2016 2
2017 2
2018 1
2021 4
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
Fanale D, Corsini LR, Scalia R, Brando C, Cucinella A, Madonia G, Dimino A, Filorizzo C, Barraco N, Bono M, Fiorino A, Magrin L, Sciacchitano R, Perez A, Russo TDB, Pantuso G, Russo A, Bazan V. Fanale D, et al. Among authors: madonia g. Crit Rev Oncol Hematol. 2022 Feb;170:103597. doi: 10.1016/j.critrevonc.2022.103597. Epub 2022 Jan 13. Crit Rev Oncol Hematol. 2022. PMID: 35033663 Review.
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors.
Incorvaia L, Madonia G, Corsini LR, Cucinella A, Brando C, Gagliardo C, Santoni M, Fanale D, Inno A, Fazio I, Foti G, Galia M, Badalamenti G, Bazan V, Russo A, Gori S. Incorvaia L, et al. Among authors: madonia g. Crit Rev Oncol Hematol. 2021 Jul;163:103390. doi: 10.1016/j.critrevonc.2021.103390. Epub 2021 Jun 4. Crit Rev Oncol Hematol. 2021. PMID: 34090998 Review.
HCV/HBV coinfection: The dark side of DAAs treatment?
Madonia S, Orlando E, Madonia G, Cannizzaro M. Madonia S, et al. Among authors: madonia g. Liver Int. 2017 Jul;37(7):1086-1087. doi: 10.1111/liv.13342. Epub 2016 Dec 28. Liver Int. 2017. PMID: 27966812 No abstract available.
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi's sarcoma without visceral involvement.
Badalamenti G, Incorvaia L, Algeri L, Bonasera A, Dimino A, Scalia R, Cucinella A, Madonia G, Pomi FL, Galvano A, Gristina V, Toia F, Cordova A, Bazan V, Russo A. Badalamenti G, et al. Among authors: madonia g. Ther Adv Med Oncol. 2022 Mar 26;14:17588359221086829. doi: 10.1177/17588359221086829. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35356263 Free PMC article.
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay.
Incorvaia L, Rinaldi G, Badalamenti G, Cucinella A, Brando C, Madonia G, Fiorino A, Pipitone A, Perez A, Li Pomi F, Galvano A, Gristina V, Barraco N, Bono M, Bazan Russo TD, Toia F, Cordova A, Fanale D, Russo A, Bazan V. Incorvaia L, et al. Among authors: madonia g. Ther Adv Med Oncol. 2023 Feb 15;15:17588359231151845. doi: 10.1177/17588359231151845. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36818688 Free PMC article.
[HYPOTONIC RECTOSIGMOIDOGRAPHY].
SCHIFINO A, PAOLINI FA, MADONIA G. SCHIFINO A, et al. Among authors: madonia g. Minerva Gastroenterol. 1964 Oct-Dec;10:208-15. Minerva Gastroenterol. 1964. PMID: 14247984 Italian. No abstract available.
[Health effects of Saharan dust in Sicily Region (Southern Italy)].
Renzi M, Stafoggia M, Cernigliaro A, Calzolari R, Madonia G, Scondotto S, Forastiere F. Renzi M, et al. Among authors: madonia g. Epidemiol Prev. 2017 Jan-Feb;41(1):46-53. doi: 10.19191/EP17.1.P046.011. Epidemiol Prev. 2017. PMID: 28322528 Italian.
30 results